Filariasis: Current status, treatment and recent advances in drug development

Current Medicinal Chemistry

Volumn 18, Issue 14, 2011, Pages 2174-2185

  Katiyar, D ^a   Singh, L K ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Brugia malayi; Filariasis control programs; Loiasis; Lymphatic filariasis; Onchocerca volvulus; Onchocerciasis; Target based antifilarial agents; Wuchereria bancrofti

Indexed keywords

2 SULFANYL 6 METHYL 1,4 DIHYDROPYRIMIDINE; 3 O ACETYLALEURITOLIC ACID; ALBENDAZOLE; ALCOHOL DERIVATIVE; ANTHRAQUINONE; ANTIFILARIAL AGENT; CAESALPINIA BONDUCELLA EXTRACT; CYCLO(DEXTRO LACTYL N METHYLLEUCYL DEXTRO 3 PHENYLLACTYL N METHYLLEUCYL DEXTRO LACTYL N METHYLLEUCYL DEXTRO 3 PHENYLLACTYL N METHYLLEUCYL); CYCLODEPSIPEPTIDE; CYCLOHEXANOL; CYCLOOCTANOL; DIETHYLCARBAMAZINE; DOXYCYCLINE; EMODEPSIDE; ENZYME INHIBITOR; GLUTATHIONE ENZYME INHIBITOR; GLUTATHIONE REDUCTASE; GLUTATHIONE SYNTHASE; GYRASE INHIBITOR; INSECTICIDE; IVERMECTIN; LANTANA CAMARA EXTRACT; MOXIDECTIN; NATURAL PRODUCT; PARASITE ANTIGEN; PLACEBO; POLYCARPOL; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VACCINE;

ARTICLE; BRUGIA MALAYI; CAENORHABDITIS ELEGANS; CONCENTRATION RESPONSE; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; DRUG SYNTHESIS; DRUG TARGETING; ENCEPHALITIS; ENZYME INHIBITION; FILARIASIS; GENE SEQUENCE; HEALTH PROGRAM; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; LOIASIS; MASTOMYS; MASTOMYS COUCHA; MEDICAL INFORMATION; MOLECULAR DOCKING; MOLECULAR GENETICS; NONHUMAN; ONCHOCERCIASIS; PHASE 2 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA HEMORRHAGE; RNA INTERFERENCE; VACCINATION; VECTOR CONTROL; VIRUS LOAD; WUCHERERIA BANCROFTI;

EID: 79957960115     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711795656234     Document Type: Article

References (132)

1. Fischer, P.; Supali, T.; Maizels, R.M. Lymphatic filariasis and Brugia timori: prospects for elimination. Trends Parasitol., 2004, 20(8), 351-355. (Pubitemid 38916522)
2. Molyneux, D.H.; Bradley, M.; Hoerauf, A.; Kyelem, D.; Taylor, M.J. Mass drug treatment for lymphatic filariasis and onchocerciasis. Trends Parasitol., 2003, 19, 516-522. (Pubitemid 37329661)
3. WHO. Global programme to eliminate lymphatic filariasis. Wkly. Epidemiol. Rec, 2008, 83, 333-341.
4. Ottesen, E.A. Lymphatic filariasis: treatment, control and elimination. Adv. Parasitol., 2006, 61, 395-441. (Pubitemid 43777024)
5. Shenoy, R.K. Clinical and pathological aspects of filarial lymphedema and its management. Korean J. Parasitol., 2008, 46, 119-125.
6. Dreyer, G.; Dreyer, P.; Piessens, W. Extra lymphatic disease due to bancroftian filariasis. Braz. J. Med. Biol. Res., 1999, 32, 1467-1472.
7. Ong, R.K.C; Doyle, R.L. Tropical pulmonary eosinophilia. Chest, 1998, 113, 1673-1679. (Pubitemid 28307176)
8. Basanez, M-G. River blindness: a success story under threat? PLoS Med., 2006, 3, e371. DOI: 10.1371/journal.pmed.0030371 (Pubitemid 44455248)
9. Hotez, P.J.; Brindley, P.J.; Bethony, J.M.; King, C.H.; Pearce, E.J.; Jacobson, J. Helminth infections: the great neglected tropical diseases. J. Clin. Invest., 2008, 118, 1311-1321. (Pubitemid 351500423)
10. Padgett, J.J.; Jacobsen, K.H. Loiasis: african eye worm. Trans. R. Soc. Trop. Med. Hyg., 2008, 102, 983-989.
11. Kamgno, J.; Pion, S.D.S.; Tejiokem, M.C.; Twum-Danso, N.A.Y.; Thylefors, B.; Boussinesq, M. Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (~25μg/kg) versus current standard dose (150μg/kg). Trans. R. Soc. Trop. Med. Hyg., 2007, 101, 777-785. (Pubitemid 46947865)
12. Yamey, G. Global alliance launches plan to eliminate lymphatic filariasis. Br. Med. J., 2000, 320, 269.
13. Kyelem, D.; Biswas, G.; Bockarie, M.J.; Bradley, M.H.; El-Setouhy, M.; Fischer, P.U.; Henderson, R.H.; Kazura, J.W.; Lammie, P.J.; Njenga, S.M.; Ottesen, E.A.; Ramaiah, K.D.; Richards, F.O.; Weil, G.J.; Williams, S.A. Determinants of success in national programmes to eliminate lymphatic filariasis: a perspective identifying essential elements and research needs. Am. J. Trop. Med. Hyg., 2008, 79, 480-484.
14. Won, K.Y.; Beau de Rochars, M.; Kyelem, D.; Streit, T.G.; Lammie, P.J. Assessing the Impact of a Missed Mass Drug Administration in Haiti. PLoS Negl. Trop. Dis., 2009, 3(8), e443. DOI:10.1371/journal.pntd.0000443
15. Boatin, B. The onchocerciasis control programme in West Africa (OCP). Ann. Trop. Med. Parasitol., 2008, 102, Suppl 1, 13-17.
16. Amazigo, U. The African programme for onchocerciasis control (APOC). Ann. Trop. Med. Parasitol., 2008, 102, Suppl 1, 19-22.
17. Sauerbery, M. The onchocerciasis elimination programme for the Americas (OEPA). Ann. Trop. Med. Parasitol., 2008, 102, Suppl 1, 25-29.
18. Winnen, M.; Plaisier, A.P.; Alley, E.S.; Nagelkerke, N.J.; van Oortmarssen, G.; Boatin, B.A.; Habbema, J.D. Can ivermectin mass treatments eliminate onchocerciasis in Africa? Bull. World Health Organ., 2002, 80, 384-390. (Pubitemid 34578791)
19. Ramaiah, K.D.; Das, P.K.; Vanamail, P.; Pani, S.P. Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis. Trans. R. Soc. Trop. Med. Hyg., 2007, 101, 555-563. (Pubitemid 46586033)
20. Tripathi, R.P.; Katiyar, D.; Dwivedi, N.; Singh, B.K.; Pandey, J. Recent developments in search of antifilarial agents. Curr. Med. Chem., 2006, 13, 3319-3334. (Pubitemid 44669778)
21. Dreyer, G.; Addiss, D.; Williamson, J.; Noroes, J. Efficacy of coadministered diethylcarbamazine and albendazole against adult Wuchereria bancrofti. Trans. R. Soc. Trop. Med. Hyg., 2006, 12, 1118-1125. (Pubitemid 44478725)
22. Klion, A.D.; Vijaykumar, A.; Oei, T.; Martin, B.; Nutman, T.B. Serum immunoglobulin G4 antibodies to the recombinant antigen, L1-SXP-1, are highly specific for Loa loa infection. J. Infect. Dis., 2003, 187, 128-133. (Pubitemid 36034481)
23. Nielsen, N.O.; Simonsen, P.E.; Dalgaard, P.; Krarup, H.; Magnussen, P.; Magesa, S.; Friis, H. Effect of diethylcarbamazine on HIV load, CD% and CD4/CD8 ratio in HIV infected adult Tanzanians with and without lymphatic filariasis: a randomized double blind and placebo-controlled cross over trials. Am. J. Trop. Med. Hyg., 2007, 77, 507-513. (Pubitemid 351844328)
24. Petersen, H.H.; Nielsen, O.N.; Monrad, J.; Magesa, S.M.; Simonsen, P.E. The effect of HIV on filarial-specific antibody response before and after treatment with diethylcarbamazine in Wuchereria bancrofti infected individuals. Parasitol. Int., 2009, 58, 141-144.
25. Esterre, P.; Plichart, C.; Sechan, Y.; Nguyen, N.L. The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort. Trop. Med. Int. Health, 2001, 6, 190-195. (Pubitemid 32281057)
26. Maizels, R.M.; Denham, D.A. Diethylcarbamazine (DEC): immunopharmacological interactions of an antifilarial drug. Parasitology, 1992, 105, S49-S60. (Pubitemid 23233503)
27. Mcgarry, H.F.; Plant L.D.; Taylor, M.J. Diethylcarbamazine activity against Brugia malayi microfilariae is dependent on inducible nitric oxide synthase and the cyclooxygenase pathway. Filaria J., 2005, 4, 4. DOI: 10.1186/1475-2883-4-4 (Pubitemid 41460790)
28. Rathaur, S.; Singh, A.; Yadav, M.; Rai, R. Evidence for the presence of prostaglandin H synthase like enzyme in female Setaria cervi and its inhibition by diethylcarbamazine. Acta Trop., 2009, 111(1), 71-77.
29. Junnila, A.; Bohle, D.S.; Prichard, R.; Perepichka, I.; Spina, C. Fluorescent diethylcarbamazine analogues: sites of accumulation in Brugia malayi. Bioconjugate Chem., 2007, 18, 1818-1823. (Pubitemid 350219979)
30. Peixotoa, C.A.; Alves, L.C.; Brayner, F.A.; Florencio, M.S. Diethylcarbamazine induces loss of microfilarial sheath of Wuchereria bancrofti. Micron, 2003, 34, 381-385. (Pubitemid 37425019)
31. Omura, S. Ivermectin: 25 years and still going strong. Int. J. Antimicrob. Agents, 2008, 31, 91-98.
32. Richard-Lenoble, D.; Chandenier, J.; Gaxotte, P. Ivermectin and filariasis. Fundam. Clin. Pharmacol., 2003, 17, 199-203. (Pubitemid 36513211)
33. Duke, B.O.L. Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms. Parasitology, 2005, 130, 447-453. (Pubitemid 40516295)
34. Awadzi, K.; Opoku, N.O.; Addy, E.T.; Quartey, B.T. The chemotherapy of onchocerciasis XIX: the clinical and laboratory tolerance of high dose ivermectin. Trop. Med. Parasitol., 1995, 46, 131-137.
35. Awadzi, K.; Boakye, D.A.; Edwards, G.; Opoku, N.O.; Attah, S.K.; Osei- Atweneboana, M.Y.; Lazdins-Helds, J.K.; Ardery, A.E.; Addy, E.T.; Quartey, B.T. An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann. Trop. Med. Parasitol., 2004, 98, 231-249. (Pubitemid 38594732)
36. Awadzi, K.; Attah, S.K.; Addy, E.T.; Opoku, N.O.; Quartey, B.T.; Lazdins- Helds, J.K.; Ahmed, K.; Boain, B. A.; Boakye, D.A.; Edwards, G. Thirty month follow up of sub-optimal responders to multiple treatment with IVM in two onchocerciasis endemic foci in Ghana. Ann. Trop. Med. Parasitol., 2004, 98, 359-370. (Pubitemid 38903480)
37. Osei-Atweneboana, M.Y.; Eng, J.K.; Boakye, D.A.; Gyapong, J.O.; Prichard, R.K. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet, 2007, 369, 2021-2029. (Pubitemid 46899181)
38. Eng, J.K.; Blackhall, W.J.; Osei-Atweneboana, M.Y.; Bouruinat, C.; Galazzo, D. Ivermectin selection on beta-tubulin: evidence in Onchocerca volvulus and Haemonchus contortus. Mol. Biochem. Parasitol., 2006, 150, 229-235. (Pubitemid 44773712)
39. Bourguinat, C.; Ardelli, B.F.; Pion, S.D.S.; Kamgno, J.; Gardon, J.; Duke, B.O.L.; Boussinesq, M.; Prichard, R.K. P-glycoprotein-like protein, a possible genetic marker for ivermectin resistance selection in Onchocerca volvulus. Mol. Biochem. Parasitol., 2008, 158, 101-111. (Pubitemid 351255520)
40. Wolstenholme, A.J.; Rogers, A.T. Glutamate-gated chloride channels and the mode of action of the avermectin/milbemycin anthelmintics. Parasitology, 2005, 131, S85-S95.
41. Brownlee, D.A.; Holden-Dye, L.; Walker, R.J. Action of the anthelmintic ivermectin on the pharyngeal muscle of the parasitic nematode Ascaris suum. Parasitology, 1997, 115, 553-561. (Pubitemid 27469661)
42. Ottesen, E.A.; Ismail, M.M.; Horton, J. The role of albendazole in programmes to eliminate LF. Parasitol. Today, 1999, 15(9), 382-86.
43. Critchley, J.; Addis, D.; Ejere, H.; Gamble, C.; Garner, P.; Gelband, H. Albendazole for the control and elimination of lymphatic filariasis: systematic review. Trop. Med. Int. Health, 2005, 10, 818-825. (Pubitemid 41291220)
44. Olsen, A. Efficacy and safety of drug combinations in the treatment of schistosomiasis, soil-transmitted helminthiasis, lymphatic filariasis and onchocerciasis. Trans. R. Soc. Trop. Med. Hyg., 2007, 101, 747-758. (Pubitemid 46930627)
45. Frayha, G.J.; Smyth, J.D.; Gobert, J.G.; Savel, J. The mechanisms of action of antiprotozoal and anthelmintic drugs in Man. Gen. Pharmacol., 1997, 28, 273-299. (Pubitemid 27016138)
46. Cotreau, M.M.; Warren, S.; Ryan, J.L.; Fleckenstein, L.; Vanapalli, S.R.; Brown, K.R.; Rock, D.; Chen, C-Yu.; Schwertschlag, U.S. The antiparasitic moxidectin: safety, tolerability, and pharmacokinetics in humans. J. Clin. Pharmacol., 2003, 43, 1108-1115. (Pubitemid 37174442)
47. Trees, A.J.; Graham, S.P.; Renz, A.; Bianco, A.E.; Tanya, V. Onchocerca ochengi infections in cattle as a model for human onchocerciasis: recent developments. Parasitology, 2000, 120, S133-S142. (Pubitemid 30326446)
48. Taylor, M.J.; Awadzi, K.; Basáñez, M.; Biritwum, N.; Boakye, D.; Boatin, B.; Bockarie, M.; Churcher, T.S.; Debrah, A.; Edwards, G.; Hoerauf, A.; Mand, S.; Matthews, G.; Osei-Atweneboana, M.; Prichard, R.K.; Wanji, S.; Adjei, O. Onchocerciasis control: vision for the future from a Ghanian perspective. Parasit. Vectors, 2009, 2, 7. DOI:10.1186/1756-3305-2-7
49. Rao, R.U. Endosymbiotic Wolbachia of parasitic filarial nematodes as drug targets. Indian J. Med. Res., 2005, 122, 199-204. (Pubitemid 41645187)
50. Taylor, M.J.; Bandi, C.; Hoerauf, A.M.; Lazdins, J. Wolbachia bacteria of filarial nematodes: a target for control? Parasitol. Today, 2000, 16, 179-180. (Pubitemid 30216558)
51. Pfarr, K.M.; Hoerauf, A.M. Antibiotics which target the Wolbachia endosymbionts of filarial parasites: a new strategy for control of filariasis and amelioration of pathology. Mini-Rev. Med. Chem., 2006, 6, 203-210.
52. Hoerauf, A.; Mand, S.; Volkmann, L.; Buttner, M.; Marfo-Debrekyei, Y.; Taylor, M.; Adjei, O.; Buttner, D.W. Doxycycline in the treatment of human onchocerciasis: kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms. Microbes Infect., 2003, 5, 261-273. (Pubitemid 36428715)
53. Hoerauf, A.; Mand, S.; Fischer, K.; Kruppa, T.; Marfo-Debrekyei, Y.; Debrah, A.Y.; Pfarr, K.M.; Adjei, O.; Buttner, D.W. Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production. Med. Microbiol. Immunol., 2003, 192, 211-216. (Pubitemid 37491681)
54. Supali, T.; Djuardi, Y.; Pfarr, K.M.; Wibowo, H.; Taylor, M.J.; Hoerauf, A.; Houwing-Duistermaat, J.J.; Yazdanbakhsh, M.; Sartono, E. Doxycycline treatment of Brugia malayi infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment. Clin. Infect. Dis., 2008, 46(9), 1385-1393. (Pubitemid 351589938)
55. Debrah, A.Y.; Mand, S.; Marfo-Debrekyei, Y.; Batsa, L.; Pfarr, K.; Buttner, M.; Adjei, O.; Buttner, D.; Hoerauf, A. Macrofilaricidal effect of 4 weeks of treatment with doxycycline on Wuchereria bancrofti. Trop. Med. Int. Health, 2007, 12, 1433-1441. (Pubitemid 350212708)
56. Hoerauf, A.; Specht, S.; Buttner, M.; Pfarr, K.; Mand, S.; Fimmers, R.; Marfo-Debrekyei, Y.; Konadu, P.; Debrah, A.Y.; Bandi, C.; Brattig, N.; Albers, A.; Larbi, J.; Batsa, L.; Adjei, O.; Buttner, D.W. Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study. Med. Microbiol. Immunol., 2008, 197, 295-311.
57. Wanji, S.; Tendongfor, N.; Nji, T.; Esum, M.; Che, J.N.; Nkwescheu, A.; Alassa, F.; Kamnang, G.; Enyong, P.A.; Taylor, M.J.; Hoerauf, A.; Taylor, D.W. Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of coendemicity with loiasis in Cameroon. Parasit. Vectors, 2009, 2, 39. DOI:10.1186/1756-3305-2-39
58. Bockarie, M.J.; Pedersen, E.M.; White, G.B.; Michael, E. Role of vector control in the global programme to eliminate lymphatic filariasis. Annu. Rev. Entomol., 2009, 54, 469-487.
59. Vedi, S.; Dangi, A.; Hajela, K.; Mishra-Bhattacharya, S. Vaccination with 73 kDa recombinant heavy chain myosin generates high level of protection against Brugia malayi challenge in jird and mastomys models. Vaccine, 2008, 26, 5997-6005.
60. Gregory, W.F.; Atmadja, A.K.; Allen, J.E.; Maizels, R.M. The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis. Infect. Immun., 2000, 68, 4174-4179. (Pubitemid 30434572)
61. Babayan, S.A.; Attout, T.; Harris, A.; Taylor, M.D.; Le Goff, L.; Vuong, P.N.; Renia, L.; Allen, J.E.; Bain, O. Vaccination against filarial nematodes with irradiated larvae provides long-term protection against the third larval stage but not against subsequent life cycle stages. Int. J. Parasitol., 2006, 36, 903-914. (Pubitemid 44866806)
62. Pokharel, D.R.; Rai, R.; Kodumudi, K.N; Reddy, M.V.; Rathaur, S. Vaccination with Setaria cervi 175 kDa collagenase induces high level of protection against Brugia malayi infection in jirds. Vaccine, 2006, 24, 6208-6215. (Pubitemid 44247246)
63. Shakya, S.; Singh, P.K.; Kushwaha, S.; Mishra-Bhattacharya, S. Adult B. malayi ~34 kDa (BMT-5) antigen offers Th1 mediated significant protection against infective larval challenge in Mastomys coucha. Parasitol. Int., 2009, 58(4), 346-353.
64. Sahoo, M.K.; Sisodia, B.S.; Dixit, S.; Joseph, S.K.; Gaur, R.L.; Verma, S.K.; Verma, A.K.; Shasany, A.K.; Dowle, A.A.; Murthy, P.K. Immunization with inflammatory proteome of Brugia malayi adult worm induces a Th1/Th2- immune response and confers protection against filarial infection. Vaccine, 2009, 27(32), 4263-4271.
65. Veerapathran, A.; Dakshinamoorthy, G.; Gnanasekar, M.; Reddy, M.V.R.; Kalyanasundaram, R. Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis. PLoS Negl Trop Dis., 2009, 3(6), e457. DOI:10.1371/journal.pntd.0000457
66. Rathaur, S.; Yadav, M.; Gupta, S.; Anandharaman, V.; Reddy, M.V. Filarial glutathione-S-transferase: a potential vaccine candidate against lymphatic filariasis. Vaccine, 2008, 26(32), 4094-5000.
67. Lustigman, S.; James, E.R.; Tawe, W.; Abraham, D. Towards a recombinant antigen vaccine against Onchocerca volvulus. Trends Parasitol., 2002, 18(3), 135-141. (Pubitemid 34164259)
68. Erttmann, K.D.; Kleensang, A.; Schneider, E.; Hammerschmidt, S.; Buttner, D.W.; Gallin, M. Cloning, characterization and DNA immunization of an Onchocerca volvulus glyceraldehyde-3-phosphate dehydrogenase (Ov- GAPDH). Biochim. Biophys. Acta, 2005, 1741, 85-94. (Pubitemid 40824993)
69. Williams, S.A.; Lizotte-Waniewski, M.R.; Foster, J.; Guiliano, D.; Daub, J.; Scott, A.L.; Slatko, B.; Blaxter, M.L. The filarial genome project: analysis of the nuclear, mitochondrial and endosymbiont genomes of Brugia malayi. Int. J. Parasitol., 2000, 30, 411-419. (Pubitemid 30145470)
70. Ghedin, E.; Wang, S.; Spiro, D.; Caler, E.; Zhao, Q.; Crabtree, J.; Allen, J.E.; Delcher, A.L.; Guiliano, D.B.; Miranda-Saavedra, D.; Angiuoli, S.V.; Creasy, T.; Amedeo, P.; Haas, B.; El-Sayed, N.M.; Wortman, J.R.; Feldblyum, T.; Tallon, L.; Schatz, M.; Shumway, M.; Koo, H.; Salzberg, S.L.; Schobel, S.; Pertea, M.; Pop, M.; White, O.; Barton, G.J.; Carlow, C.K.; Crawford, M.J.; Daub, J.; Dimmic, M.W.; Estes, C.F.; Foster, J.M.; Ganatra, M.; Gregory, W.F.; Johnson, N.M.; Jin, J.; Komuniecki, R.; Korf, I.; Kumar, S.; Laney, S.; Li, B-W.; Li, W.; Lindblom, T.H.; Lustigman, S.; Ma, D.; Maina, C.V.; Martin, D.M.A.; McCarter, J.P.; McReynolds, L.; Mitreva, M.; Nutman, T.B.; Parkinson, J.; Peregrín-Alvarez, J.M.; Poole, C.; Ren, Q.; Saunders, L.; Sluder, A.E.; Smith, K.; Stanke, M.; Unnasch, T.R.; Ware, J.; Wei, A.D.; Weil, G.; Williams, D.J.; Zhang, Y.; Williams, S.A.; Fraser- Liggett, C.; Slatko, B.; Blaxter, M.L.; Scott, A.L. Draft genome of the filarial nematode parasite Brugia malayi. Science, 2007, 317, 1756-1760. (Pubitemid 47461841)
71. Scott, A.L; Ghedin, E. The genome of Brugia malayi-all worms are not created equal. Parasitol. Int., 2009, 58, 6-11.
72. Pennisi, E. The human genome. Science, 2001, 291(5507), 1177-1180. (Pubitemid 32173064)
73. Foster, J.; Ganatra, M.; Kamal, I.; Ware, J.; Makarova, K.; Ivanova, N.; Bhattacharyya, A.; Kapatral, V.; Kumar, S.; Posfai, J.; Vincze, T.; Ingram, J.; Moran, L.; Lapidus, A.; Omelchenko, M.; Kyrpides, N.; Ghedin, E.; Wang, S.; Goltsman, E.; Joukov, V.; Ostrovskaya, O.; Tsukerman, K.; Mazur, M.; Comb, D.; Koonin, E.; Slatko, B. The Wolbachia genome of Brugia malayi: endosymbiont evolution within a human pathogenic nematode. PLoS Biol., 2005, 3, e121.
74. Dieterich, C.; Sommer, R.J. How to become a parasite lessons from the genomes of nematodes. Trends Genet., 2009, 25(5), 203-209.
75. Singh, A.R.; Joshi, S.; Arya, R.; Kayastha, A.M.; Srivastava, K.K.; Tripathi, L.M.; Saxena, J.K. Molecular cloning and characterization of Brugia malayi hexokinase. Parasitol. Int., 2008, 57, 354-361.
76. Behm, C.A.; Bendig, M.M.; McCarter, J.P.; Sluder, A.E. RNAi-based discovery and validation of new drug targets in filarial nematodes. Trends Parasitol., 2005, 21, 97-100. (Pubitemid 40269770)
77. Knox, D.P.; Geldhof, P.; Visser, A.; Britton, C. RNA interference in parasitic nematodes of animals: a reality check. Trends Parasitol., 2007, 23, 105-107.
78. McNulty, S.N.; Weil, G.J.; Heinz, M.; Crosby, S.D.; Fischer, P.U. Brugia malayi: whole genome amplification for genomic characterization of filarial parasites. Exp. Parasitol., 2008, 119, 256-263.
79. Sharma, S. Design of new drugs for helminth diseases: lead optimization in benzimidazole. Adv. Drug Res., 1994, 25, 103-172. (Pubitemid 24141321)
80. Ram, S.; Wise, D.S.; Wotring, L.L.; McCall, J.W.; Townsend, L.B. Synthesis and biological activity of certain alkyl 5-(alkoxycarbonyl)- 1Hbenzimidazole- 2-carbamates and related derivatives: a new class of potential antineoplastic and antifilarial agents. J. Med. Chem., 1992, 35(3), 539-547.
81. Ginger, C.D. Advances in filarial chemotherapy and screening. Parasitol. Today, 1986, 2(2), 38-40. (Pubitemid 17035825)
82. Loiseau, P.M.; Depreux, P. In vitro antifilarial evaluation of phenoxycyclohexane derivatives. Ann. Trop. Med. Parasitol., 1993, 87(6), 469-476. (Pubitemid 24002531)
83. Srivastava, S.; Agarwal, A.; Chauhan, P.M.S. Potent 1,3-disubstituted- 9Hpyrido[ 3,4-b] indoles as new lead compounds in antifilarial chemotherapy. J. Med. Chem., 1999, 42, 1667-1672. (Pubitemid 29226736)
84. Srivastava, S.K.; Chauhan, P.M.S.; Bhaduri, A.P.; Fatima, N.; Chatterjee, R.K. Quinolones: novel probes in antifilarial chemotherapy. J. Med. Chem., 2000, 43, 2275-2279. (Pubitemid 30354552)
85. Chauhan, P.M.S.; Chatterjee, R.K. Synthesis of 1,3-substituted indoles, 2,4,6-substituted-s-triazines and 4,5-substituted pyrazoles as possible antifilarial agents. Indian J. Chem., 1994, 33B, 32-37.
86. Srivastava, S.K.; Chauhan, P.M.S.; Agarwal, S.K.; Bhaduri, A.P.; Singh, S.N.; Fatma, N.; Chatterjee, R.K.; Bose, C.; Srivastava, V.M.L. Synthesis and antifilarial profile of 5-amino and 5,8-diamino isoquinoline derivatives: a new class of antifilarial agents. Bioorg. Med. Chem. Lett., 1996, 6(22), 2623-2628. (Pubitemid 26387234)
87. Tewari, S.; Chauhan, P.M.S.; Bhaduri, A.P.; Singh, S.N.; Fatma, N.; Chatterjee, R.K.; Srivastava, V.M.L. 1,1'-Dicyano-2-substituted ethylenes: a new class of glucose uptake inhibitors in antifilarial chemotherapy. Bioorg. Med. Chem. Lett., 1997, 7(14), 1891-1896. (Pubitemid 27317810)
88. Srivastava, S.K.; Chauhan, P.M.S.; Bhaduri, A.P.; Murthy, P.K.; Chatterjee, R.K. Secondary amines as new pharmacophores for macrofilaricidal drug design. Bioorg. Med. Chem. Lett., 2000, 10, 313-314. (Pubitemid 30125178)
89. Sundberg, R.J.; Biswas, S.; Murthi, K.K.; Rowe, D.; McCall, J.W.; Dzimianski, M.T. Bis-cationic heteroaromatics as macrofilaricides: synthesis of bis-amidine and bis-guanylhydrazone derivatives of substituted imidazo [1,2-a] pyridines. J. Med. Chem.,1998, 41(22), 4317-4328. (Pubitemid 28498755)
90. Angelo, M.; Ortwine, D.; Worth, D.; Werbel, L.M.; McCall, J.W. Synthesis and antifilarial activity of N-[4-[[4-alkoxy-3-[(dialkylamino)methyl]phenyl] amino]-2-pyrimidinyl]-N'-phenylguanidines. J. Med. Chem., 1983, 26, 1258-1267.
91. Tewari, S.; Chauhan, P.M.S.; Bhaduri, A.P.; Fatima, N.; Chatterjee, R.K. Synthesis and antifilarial profile of 7-chloro-4-(substituted amino) quinolines: a new class of antifilarial agents. Bioorg. Med. Chem. Lett., 2000, 10, 1409-1412. (Pubitemid 30392074)
92. Tripathi, R.P.; Tiwari, V.K.; Bhattacharya, S.M.; Tyagi, K.; Srivastava, V.M.L.; Murthy, P.K. 7-O-[4-methyl piperazine-1-(2-acetyl)]-2H-1- benzopyran-2-one: a novel antifilarial lead compound. Acta Trop., 2003, 87(2), 215-224. (Pubitemid 36776308)
93. Katiyar, D.; Tiwari, V.K.; Tripathi, R.P.; Reddy, V.M.; Bhattacharya, S.M.; Saxena, J.K. Synthesis and antifilarial evaluation of 7-O-acetamidyl-4- alkyl- 2H-1-benzopyran-2-ones. Arzneim-forsch/Drug Res., 2003, 53, 857-863. (Pubitemid 38021436)
94. Bhattacharya, S.M.; Katiyar, D.; Bajpai, P.; Tripathi, R.P.; Saxena, J.K. 4- Methyl-7-(tetradecanoyl)-2H-1-benzopyran-2-one: a novel DNA topoisomerase II inhibitor with adulticidal and embryostatic activity against sub-periodic Brugia malayi. Parasitol. Res., 2004, 92, 177-182. (Pubitemid 38230467)
95. Khan, A.R.; Tripathi, R.P.; Tiwari, V.K.; Mishra, R.C.; Reddy, V.J.M.; Saxena, J.K. Conjugate addition of amines to sugar derived olefinic esters: synthesis of glucosylated amino esters as DNA topoisomerse-II inhibitors. J. Carb. Chem., 2002, 21(6), 591-604. (Pubitemid 36057203)
96. n-xylofuranosylated diaminoalkanes. Bioorg. Med. Chem., 2003, 11, 1789-1800. (Pubitemid 36349160)
97. Singh, S.N.; Bhatnagar, S.; Fatma, N.; Chauhan, P.M.S.; Chatterjee, R.K. Antifilarial activity of a synthetic marine alkaloid, aplysinopsin (CDRI Compound 92/138). Trop. Med. Int. Health, 1997, 2(6), 535-543. (Pubitemid 27304332)
98. Loiseau, P.M.; Bourass, J.; Letourneux, Y. Lymphotropic antifilarial agents derived from closental and chlorambucil. Int. J. Parasitol., 1997, 27, 443-447. (Pubitemid 27241526)
99. Mathew, N.; Kalyanasundaram, M. Antifilarial agents. Expert Opin. Ther. Patents, 2007, 17(7), 1-22.
100. Gupta, S.; Srivastava, A.K. Biochemical targets in filarial worms for selective antifilarial drug design. Acta Parasitol., 2005, 50(1), 1-18.
101. Ahmad, R.; Srivastava, A.K. Biochemical composition and metabolic pathways of filarial worms Setaria cervi: search for new antifilarial agents. J. Helminthol., 2007, 81, 261-280. (Pubitemid 47417547)
102. Gupta, S.; Srivastava, A.K. Glutathione metabolism of filarial worms: a vulnerable target for the design and synthesis of new antifilarial agents. Med. Sci. Monit., 2006, 12, HY1-9. (Pubitemid 43332273)
103. Torres-Rivera, A.; Landa, A. Glutathione transferases from parasites: a biochemical view. Acta Trop., 2008, 105, 99-112.
104. Ahmad, R.; Srivastava, A.K.; Walter, R.D. Purification and biochemical characterization of cytosolic glutathione-S-transferase from filarial worms Setaria cervi. Comparative Biochem. Physiol., 2008, Part B 151, 237-245.
105. Muller, S.; Gilberger, T-W.; Fairlamb, A.H.; Walter, R.D. Molecular characterization and expression of Onchocerca volvulus glutathione reductase. Biochem. J., 1997, 325, 645-651. (Pubitemid 27367753)
106. Rathaur, S.; Fischer, P.; Domagalski, M.; Walter, R.D.; Liebau, E. Brugia malayi and Wuchereria bancrofti: gene comparison and recombinant expression of p-class related glutathione-S-transferases. Exp. Parasitol., 2003, 103, 177-181. (Pubitemid 36918195)
107. Bhargavi, R.; Vishwakarma, S.; Murty, U.S. Modelling analysis of GST from Wuchereria bancrofti and Brugia malayi. Bioinformation, 2005, 1(1), 25-27.
108. Perbandt, M.; Hoppner, J.; Betzel, C.; Walter, R.D.; Liebau, E. Structure of the major cytosolic glutathione-S-transferase from the parasitic nematode Onchocerca volvulus. J. Biol. Chem., 2005, 280, 12630-12636.
109. Nathan, S.T.; Mathew, N.; Kalyanasundaram, M.; Balaraman, K. Structure of glutathione-S-transferase of the filarial parasite Wuchereria bancrofti: a target for drug development against adult worm. J. Mol. Model., 2005, 11, 194-199. (Pubitemid 40974158)
110. Awasthi, S.K.; Mishra, N.; Dixit, S.K.; Singh, A.; Yadav, M.; Yadav, S.S.; Rathaur, S. Antifilarial activity of 1,3-diarylpropen-1-one: effect on glutathione-S-transferase, a phase II detoxification enzyme. Am. J. Trop. Med. Hyg., 2009, 80, 764-68.
111. Pandya, U.; Saxena, J.K.; Kaul, S.M.; Murthy, P.K.; Chatterjee, R.K.; Tripathi, R.P.; Bhaduri, A.P.; Shukla, O.P. DNA topoisomerases of filarial parasites: effect of antifilarial compounds. Med. Sci. Res., 1999, 27, 103-105. (Pubitemid 29110341)
112. Tripathi, R.P.; Rastogi, S.K.; Kundu, B.; Saxena, J.K.; Reddy, V.J.M.; Shrivastav, S.; Chandra, S.; Bhaduri, A.P. Identification of inhibitors of DNA topoisomerase-II from a synthetic library of glycoconjugates. Comb. Chem. Throughput Screen., 2001, 4, 237-244. (Pubitemid 32433636)
113. Peacock, A.F.A.; Habtemariam, A.; Fernandez, R.; Walland, V.; Fabbiani, F.P.A.; Parsons, S.; Aird, R.E.; Jodrell, D.I.; Sadler, P.J. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions. J. Am. Chem. Soc., 2006, 128(5), 1739-1748. (Pubitemid 43214890)
114. Chandra, M.; Sahay, A.N.; Pandey, D.S.; Tripathi, R.P.; Saxena, J.K.; Reddy, V.J.M.; Puerta, M.C.; Valerga, P. Potential inhibitors of DNA topoisomerase II: ruthenium(II) poly-pyridyl and pyridyl-azine complexes. J. Organomet. Chem., 2004, 689, 2256-2267.
115. Singh, S.K.; Joshi, S.; Singh, A.R.; Saxena, J.K.; Pandey, D.S. DNA binding and topoisomerase II inhibitory activity of water-soluble ruthenium(II) and rhodium (III) complexes. Inorg. Chem., 2007, 46, 10869-10876.
116. Sharma, S.; Singh, S.K.; Pandey, D.S. Ruthenium (II) polypyridyl complexes: potential precursors, metalloligands, and Topo II inhibitors. Inorg. Chem., 2008, 47, 1179-1189.
117. Katiyar, S.B.; Bansal, I.; Saxena, J.K.; Chauhan, P.M.S. Syntheses of 2,4,6- trisubstituted pyrimidine derivatives as a new class of antifilarial topoisomerase II inhibitors. Bioorg. Med. Chem. Lett., 2005, 15, 47-50. (Pubitemid 39575780)
118. Kumar, A.; Saxena, J.K.; Chauhan, P.M.S. Synthesis of 4-amino-5-cyano- 2,6-disubstituted pyrimidines as a potential antifilarial DNA topoisomerase II inhibitors. Med. Chem., 2008, 4, 577-585.
119. Dhananjeyan, M.R.; Milev, Y.P.; Kron, M.A.; Nair, M.G. Synthesis and activity of substituted anthraquinones against a human filarial parasite, Brugia malayi. J. Med. Chem., 2005, 48, 2822-2830. (Pubitemid 40548097)
120. Singh, B.K.; Mishra, M.; Saxena, N.; Yadav, G.P.; Maulik, P.R.; Sahoo, M.K.; Gaur, R.L.; Murthy, P.K.; Tripathi, R.P. Synthesis of 2-sulfanyl-6- methyl-1,4-dihydropyrimidines as a new class of antifilarial agents. Eur. J. Med. Chem., 2008, 43, 2717-2723.
121. Agarwal, A.; Awasthi, S.K.; Murthy, P.K. In vivo antifilarial activity of some cyclic and acylic alcohols. Med. Chem. Res., 2010. DOI 10.1007/s00044-010-9331-4.
122. Tagboto, S.; Townson, S. Antiparasitic properties of medicinal plants and other naturally occurring products. Adv. Parasitol., 2001, 50, 199-295. (Pubitemid 33086304)
123. Lemmens-Gruber, R.; Kamyar, M.R.; Dornetshuber, R. Cyclodepsipeptidespotential drugs and lead compounds in the drug development process. Curr. Med. Chem., 2009, 16(9), 1122-1137.
124. Zahner, H.; Taubert, A.; Harder, A.; von Samson-Himmelstjerna, G. Effects of BAY 44-4400, a new cyclodepsipeptide, on developing stages of filariae (Acanthocheilonema viteae, Brugia malayi, Litomosoides sigmodontis) in the rodent Mastomys coucha. Acta Trop., 2001, 80, 19-28. (Pubitemid 32728391)
125. Zahner, H.; Taubert, A.; Harder, A.; von Samson-Himmelstjerna, G. Filaricidal efficacy of anthelmintically active cyclodepsipeptides. Int. J. Parasitol., 2001, 31, 1515-1522. (Pubitemid 32947006)
126. Harder, A.; Schmitt-Wrede, H-P.; Krucken, J.; Marinovski, P.; Wunderlich, F.; Willson, J.; Amliwala, K.; Holden-Dye, L.; Walker, R. Cyclooctadepsipeptides: an anthelmintically active class of compounds exhibiting a novel mode of action. Int. J. Antimicrob. Agents, 2003, 22, 318-331. (Pubitemid 37103217)
127. Nyasse, B.; Ngantchou, I.; Nono, J.J.; Schneider, B. Antifilarial activity in vitro of polycarpol and 3-O-acetyl aleuritolic acid from cameroonian medicinal plants against Onchocerca gutturosa. Nat. Prod. Res., 2006, 20, 391-397. (Pubitemid 43675137)
128. Gaur, R.L. Antifilarial activity of Caesalpinia bonducella against experimental filarial infections. Indian J. Med.Res., 2008, 128, 65-70.
129. Misra, N.; Sharma, M.; Raj, K.; Dangi, A.; Srivastava, S.; Misra- Bhattacharya, S. Chemical constituents and antifilarial activity of Lantana camara against human lymphatic filariid Brugia malayi and rodent filariid Acanthocheilonema viteae maintained in rodent hosts. Parasitol. Res., 2007, 100, 439-448. (Pubitemid 46011252)
130. Mathew, N.; Misra-Bhattacharya, S.; Vanamail, P.; Kalyanasundaram, M. Antifilarial lead molecules isolated from Trachyspermum ammi. Molecules, 2008, 13, 2156-2168.
131. Lakshmi, V.; Srivastava, S.; Mishra, S.K.; Misra, S.; Verma, M.; Bhattacharya, S.M. In vitro and in vivo antifilarial potential of marine sponge, Haliclona exigua (Kirkpatrick), against human lymphatic filarial parasite Brugia malayi. Parasitol. Res., 2009, 105, 1295-1301.
132. Weil, G.J.; Ramzy, R.M.R. Diagnostic tools for filariasis elimination programmes. Trends Parasitol., 2006, 23, 78-82.